Background alzheimers Shape Background alzheimers Shape Background alzheimers Shape
Grants > Caspase-Independent Pathway of Amyloid-Beta Cytotoxicity Updated On: Jan. 19, 2025
Alzheimer's Disease Research Grant

Caspase-Independent Pathway of Amyloid-Beta Cytotoxicity

BFF logo

Principal Investigator

Alexei Degterev, PhD

Harvard Medical School

Boston, MA, USA

About the Research Project

Program

Alzheimer's Disease Research

Award Type

Standard

Award Amount

$100,000

Active Dates

April 01, 2003 - March 31, 2005

Grant ID

A2003223

Summary

Neuronal loss induced by oligomerized amyloid beta (Aß) peptide is an important feature of Alzheimer’s disease. It has been proposed that apoptotic cell death, the body’s own suicide program to ensure the elimination of dangerous cells, may contribute to the neuronal loss in AD. However, the inhibition of caspases, a family of proteases that execute apoptosis, only partially relieves the cytotoxicity induced by AD, which suggests that other, caspase-independent cell death pathways must exist. In previous work, Dr. Degterev defined a novel caspase-independent cell death pathway named “aponecrosis.” He identified two inhibitors (ANI1 and ANI2) that specifically inhibit aponecrosis in a number of cell types. The major goal of this study is to identify the molecular mechanism of the aponecrotic pathway induced by Aß in vitro and to define its role in animal models of AD. Ultimately, this work could lead to the identification of novel molecular targets for drug interventions in AD, and ANIs may serve as potential prototypes and/or target compounds in the development of new AD treatments.